BioCryst Pharmaceuticals
BCRX
#5121
Rank
โ‚ฌ1.33 B
Marketcap
6,33ย โ‚ฌ
Share price
-1.91%
Change (1 day)
-15.37%
Change (1 year)

Earnings for BioCryst Pharmaceuticals (BCRX)

Earnings in 2025 (TTM): -โ‚ฌ8.44 Million

According to BioCryst Pharmaceuticals 's latest financial reports the company's current earnings are โ‚ฌ0.59 Billion. In 2024 the company made an earning of -โ‚ฌ74.05 Million, an increase over its 2023 earnings that were of -โ‚ฌ0.2 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioCryst Pharmaceuticals from 1994 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ8.44 Million-88.6%
2024 -โ‚ฌ74.05 Million-61.56%
2023 -โ‚ฌ0.2 Billion-7.43%
2022 -โ‚ฌ0.21 Billion34.42%
2021 -โ‚ฌ0.16 Billion-0.55%
2020 -โ‚ฌ0.16 Billion67.88%
2019 -โ‚ฌ92.73 Million7.55%
2018 -โ‚ฌ86.22 Million53.92%
2017 -โ‚ฌ56.02 Million19.29%
2016 -โ‚ฌ46.96 Million28.19%
2015 -โ‚ฌ36.64 Million-4.8%
2014 -โ‚ฌ38.48 Million50.09%
2013 -โ‚ฌ25.64 Million-23.29%
2012 -โ‚ฌ33.43 Million-26.19%
2011 -โ‚ฌ45.28 Million54.78%
2010 -โ‚ฌ29.26 Million150.1%
2009 -โ‚ฌ11.7 Million-49.43%
2008 -โ‚ฌ23.14 Million14.07%
2007 -โ‚ฌ20.28 Million-49.31%
2006 -โ‚ฌ40.01 Million72.87%
2005 -โ‚ฌ23.15 Million22.08%
2004 -โ‚ฌ18.96 Million75.3%
2003 -โ‚ฌ10.82 Million-25.36%
2002 -โ‚ฌ14.49 Million225.05%
2001 -โ‚ฌ4.46 Million-56.6%
2000 -โ‚ฌ10.27 Million50.63%
1999 -โ‚ฌ6.82 Million38.05%
1998 -โ‚ฌ4.94 Million-52.46%
1997 -โ‚ฌ10.39 Million58.44%
1996 -โ‚ฌ6.56 Million-14.44%
1995 -โ‚ฌ7.67 Million28.57%
1994 -โ‚ฌ5.97 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Repligen
RGEN
โ‚ฌ22.25 M-495.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-โ‚ฌ0.22 Billion 3,711.18%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-โ‚ฌ8.07 Million 43.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚ฌ0.31 B-5,767.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ8.41 B-149,503.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚ฌ0.22 Billion 3,772.45%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ7.93 B-140,993.15%๐Ÿ‡ฌ๐Ÿ‡ง UK
Emergent BioSolutions
EBS
โ‚ฌ0.14 B-2,598.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-โ‚ฌ21.06 Million 273.65%๐Ÿ‡บ๐Ÿ‡ธ USA